Multi-Omic Regulation of the PAM50 Gene Signature in Breast Cancer Molecular Subtypes
Breast cancer is a disease that exhibits heterogeneity that goes from the genomic to the clinical levels. This heterogeneity is thought to be captured (at least partially) by the so-called breast cancer molecular subtypes. These molecular subtypes were initially defined based on the unsupervised clu...
Main Authors: | Soledad Ochoa, Guillermo de Anda-Jáuregui, Enrique Hernández-Lemus |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00845/full |
Similar Items
-
Multi-Omics Analysis Detects Novel Prognostic Subgroups of Breast Cancer
by: Quang-Huy Nguyen, et al.
Published: (2020-10-01) -
Computational Oncology in the Multi-Omics Era: State of the Art
by: Guillermo de Anda-Jáuregui, et al.
Published: (2020-04-01) -
PAM50 Intrinsic Subtype Profiles in Primary and Metastatic Breast Cancer Show a Significant Shift toward More Aggressive Subtypes with Prognostic Implications
by: Charlotte Levin Tykjær Jørgensen, et al.
Published: (2021-03-01) -
A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer
by: Tomás Pascual, et al.
Published: (2019-04-01) -
Quantification of intrinsic subtype ambiguity in Luminal A breast cancer and its relationship to clinical outcomes
by: Neeraj Kumar, et al.
Published: (2019-03-01)